Blood and urine testing
Because an increased risk of bleeding and kidney damage has been seen in similar medications, individuals taking SPINRAZA may be at similar risk.
It is recommended that your healthcare provider (HCP) perform blood and urine testing before starting treatment and again before each dose to monitor for signs of these risks.
Common adverse events (AEs)
In clinical studies, the most common AEs seen with SPINRAZA were lower and upper respiratory infections, constipation, headache, back pain, and post-lumbar puncture syndrome (headache related to the intrathecal procedure).
"It’s the joy of simple things. Each one of her minor movements has been monumental to us. It’s amazing and breathtaking every time."
- Ruby and Emma’s mother